Search

Jerrie A Gavalchin

from Groton, NY
Age ~69

Jerrie Gavalchin Phones & Addresses

  • 117 Devlen Rd, Groton, NY 13073
  • Santa Fe, NM
  • Forked River, NJ
  • Boston, MA
  • Ocean, NJ

Work

Position: Financial Professional

Education

Degree: Associate degree or higher

Publications

Us Patents

Lateral Flow Based Methods And Assays For Rapid And Inexpensive Diagnostic Tests

View page
US Patent:
20110165559, Jul 7, 2011
Filed:
Sep 17, 2010
Appl. No.:
12/807978
Inventors:
Michael J. Lane - Baldwinsville NY, US
Brian D. Faldasz - Littleton MA, US
Jerrie Gavalchin - Groton NY, US
International Classification:
C12Q 1/68
G01N 33/53
US Classification:
435 61, 435 71, 435 79
Abstract:
The invention provides reagents and methods for lateral flow assays and quantitative capture or determination of components, including cells, in a sample. In one aspect, reagents and methods for diagnostic assay are provided. In one embodiment an assay for determining T cell numbers, particularly a CD2+ CD4+ T cell assay is provided. A manufacturing method for producing rapid diagnostic assays in a decentralized manner is also described. The method generates net economic advantages over conventional diagnostic manufacturing practices.

Methods And Compositions For Multivalent Binding And Methods For Manufacture Of Rapid Diagnostic Tests

View page
US Patent:
20100143905, Jun 10, 2010
Filed:
Mar 28, 2008
Appl. No.:
12/450532
Inventors:
Michael J. Lane - Baldwinsville NY, US
Jerrie Gavalchin - Groton NY, US
Brian D. Faldasz - Littleton MA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The invention provides reagents and methods for multivalent binding and quantitative capture of components in a sample. In one aspect, reagents and methods for diagnostic assay for antigen, ligand, binding agent, or antibody are provided. Compositions of a non-natural or deliberately constructed nucleic acid-like polymeric scaffold are provided, to which multiple antibodies, peptides or other binding agents can be affixed by hybridization of a oligonucleotide: binding agent complex such that the nucleic acid: binding agent construction displays multivalent behavior when interacting with a multivalent analyte. Methods for constructing and using the scaffolds are described. Such compositions may include assembly of mixed specificity binding agents such that the composition displays multivalent binding behavior against a target containing mixed analytes which can be bound by the construct to effect a binding affinity increase such as is observed in avidity reagents against single analytes expressed multiply on the target analyte. A manufacturing method for producing rapid diagnostic assays in a decentralized manner is also described. The method generates net economic advantages over conventional diagnostic manufacturing practices.
Jerrie A Gavalchin from Groton, NY, age ~69 Get Report